Although several growth factor receptors, such as epidermal growth factor receptor, ErbB2 and FGFR1, have been studied and implicated in breast cancer, we are only beginning to understand how these growth factor pathways interact with other autocrine or paracrine factors to promote tumourigenesis. The gene discussed is FGFR1; the disease is breast cancer.